Literature DB >> 15930838

Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.

J Steven McDougal1, Christopher D Pilcher, Bharat S Parekh, Guy Gershy-Damet, Bernard M Branson, Kimberly Marsh, Stefan Z Wiktor.   

Abstract

Over the past few years, several assays have been developed for the purpose of estimating HIV-1 incidence from cross-sectional population surveys. The tests detect features of the evolving virological or immunological response to HIV-1 infection that distinguish recent from established infection. Surveillance programmes that collect specimens from population surveys for HIV-1 prevalence can apply some of these tests to the same specimen sets to estimate incidence. We describe these tests and discuss the principle and strategy for implementation of a testing programme for recent infection in surveillance settings. Test-specific prerequisites, such as calibration, validation, and quality assurance, and other test-specific performance characteristics that may influence interpretation, epidemiological considerations that may guide application, and practical operational considerations for implementation in surveillance settings are considered. When properly and judiciously applied, the capacity to estimate incidence from existing programmes that conduct surveillance for prevalent HIV-1 infection will enhance the capacity for more precise and timely analysis of the dynamics of the epidemic and the effectiveness of public health interventions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930838     DOI: 10.1097/01.aids.0000172874.90133.7a

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  28 in total

1.  Strengthening HIV surveillance: measurements to track the epidemic in real time.

Authors:  Usangiphile E Buthelezi; Candace L Davidson; Ayesha Bm Kharsany
Journal:  Afr J AIDS Res       Date:  2016-07       Impact factor: 1.300

Review 2.  Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics.

Authors:  P D Ghys; E Kufa; M V George
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

3.  Seroincidence of recent human immunodeficiency virus type 1 infections in China.

Authors:  Yao Xiao; Yan Jiang; Jigang Feng; Wenyan Xu; Minjie Wang; Ellen Funkhouser; Sten H Vermund; Yujiang Jia
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

4.  Laboratory support of global health research.

Authors:  Barbara Van Der Pol
Journal:  J Gen Intern Med       Date:  2013-09       Impact factor: 5.128

5.  Using tests for recent infection to estimate incidence: problems and prospects for HIV.

Authors:  A Welte; T A McWalter; O Laeyendecker; T B Hallett
Journal:  Euro Surveill       Date:  2010-06-17

6.  HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics.

Authors:  John Kinuthia; Alison L Drake; Daniel Matemo; Barbra A Richardson; Clement Zeh; Lusi Osborn; Julie Overbaugh; R Scott McClelland; Grace John-Stewart
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

Review 7.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

Review 8.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

9.  Identification of primary HIV-1C infection in Botswana.

Authors:  V Novitsky; E Woldegabriel; C Wester; E McDonald; R Rossenkhan; M Ketunuti; J Makhema; G R Seage; M Essex
Journal:  AIDS Care       Date:  2008-08

10.  Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age.

Authors:  Timothy B Hallett; Peter Ghys; Till Bärnighausen; Ping Yan; Geoff P Garnett
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.